Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for MolPort-001-783-406 Active Pharmaceutical Ingredient (API)

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    MolPort-001-783-406

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 106,772Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    19/05/2020 Emcure Pharmaceuticals
    India
    		 M/s Emcure Pharmaceuticals Ltd WC-0226 Busulfan (USP) 2019-10-07 2022-07-02 D-24 and D24/1 MIDC Kurkumbh Tal. Daund, Dist Pune 413 802, Maharashtra State
    29/04/2020 Fresenius Kabi Oncology Limited
    India
    		 M/s. Fresenius Kabi Oncology Ltd.,  WC-0115 Busulfan (USP/EP/BP) 2019-07-08 2022-07-07 D-35, Industrial Area, Kalyani, Dist Nadia-741 235, West Bengal